TELA Bio

TELA Bio Financial Leverage

The Financial Leverage (Equity Multiplier) of TELA Bio (TELA) as of Nov 4, 2026 is 12.90. In the previous year, Financial Leverage (Equity Multiplier) was 3.07 — a change of 320.29% (higher).

Financial Leverage

12.90

YoY

320.29%

Last updated:

Financial Leverage (Equity Multiplier) of TELA Bio is 2025 12.90 . Financial Leverage (Equity Multiplier) of TELA Bio was 2024 3.07 . It decreases by 320.29% higher compared to the previous year.

The TELA Bio Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
-0.20 USD
Jan 1, 2019
2.19 USD
Jan 1, 2020
1.76 USD
Jan 1, 2021
3.11 USD
Jan 1, 2022
4.74 USD
Jan 1, 2023
4.13 USD
Jan 1, 2024
3.07 USD
Jan 1, 2025
12.90 USD
The TELA Bio Financial Leverage history
YEARFinancial LeverageYoY
12.90+320.29%
3.07-25.77%
4.13-12.85%
4.74+52.43%
3.11+76.46%
1.76-19.61%
2.19-1,210.76%
-0.20+37.55%
-0.14—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

TELA Bio Stock analysis

What does TELA Bio do? TELA Bio Inc is an American medical technology company that specializes in the development and manufacture of innovative surgical implants. The history of this company began in 2012 when a group of experienced bioengineers and medical professionals decided to develop a better surgical tissue replacement material. The idea was to create a product that not only supports the healing process but is also safe, durable, and easy to handle. Over the years, TELA Bio has successfully implemented the business model of complete vertical integration, which means that the company takes care of everything from research and development to production, distribution, and marketing of its products. This allows the company to build closer relationships with its customers and improve the quality of its products by addressing the needs and requirements of its users. The core business of TELA Bio focuses on a wide range of surgical tissue replacement materials specifically designed for plastic and reconstructive surgery, hernia repair, and wound healing. These products are characterized by their high biocompatibility, strength, and flexibility, and provide a safe and effective solution for a variety of medical applications. Key products offered by TELA Bio include the OviTex® product family, which includes surgical mesh materials for supporting wound healing in hernia repairs and abdominal surgeries, as well as tissue replacement materials for breast reconstruction after mastectomy. These products are known for their high biocompatibility and ability to integrate into the surrounding tissue and restore natural tissue structures. In addition, TELA Bio also offers the TELADERM®-DH product, specifically developed for wound healing in diabetes patients. This product consists of a tissue replacement material that supports skin repair and reduces the risk of infection, particularly in patients with poorly healing wounds. Overall, TELA Bio has developed a wide range of products tailored to the needs of modern medicine. The company is focused on improving the quality of medical care and providing innovative solutions for surgical wound healing. With its successful implementations in research, production, and distribution, TELA Bio is well-positioned to continue growing and solidify its position as a leading provider of medical implants. TELA Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about TELA Bio stock

Financial Leverage (Equity Multiplier) of TELA Bio is 12.90 in 2025.

Financial Leverage (Equity Multiplier) of TELA Bio changed from 3.07 to 12.90, representing a 320.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) TELA Bio since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s TELA Bio with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — TELA Bio

All Key Metrics — TELA Bio